Back to results
US 11,634,406 B2Granted
Inhibitor of p38 MAP kinase
AssigneeRespivert Limited
InventorsAlistair Ian Longshaw, Euan Alexander Fraser Fordyce, Stuart Thomas Onions, John King-Underwood, Jennifer Venable
Life of this patent
Estimating the term…
Abstract
A compound has the following formula: The compound is a p38 MAP kinase inhibitor. The compound and its pharmaceutically acceptable salts can be used for treatment of conditions, such as inflammatory diseases.
Claims10
A method of treatment of a condition selected from exacerbation of COPD and exacerbation of asthma comprising administering to a subject in need thereof an effective amount of a compound of formula (I)
- or a pharmaceutically acceptable salt thereof, including all stereoisomers and tautomers thereof.
Dependencies are inferred from the claim text.